Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12617000531314Phase 4Completed
Phase 4, randomised trial in chronic periodontitis comparing OSFD + placebo with OSFD + azithromycin (2 arms). Primary endpoint: Difference in clinical probing pocket depth reduction. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12617000531314.